APA (7th ed.) Citation

Angoulvant, D., Sabouret, P., & Savage, M. P. (2021). NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View. American Journal of Cardiovascular Drugs, 21(5), 483. https://doi.org/10.1007/s40256-021-00471-z

Chicago Style (17th ed.) Citation

Angoulvant, Denis, Pierre Sabouret, and Michael P. Savage. "NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View." American Journal of Cardiovascular Drugs 21, no. 5 (2021): 483. https://doi.org/10.1007/s40256-021-00471-z.

MLA (9th ed.) Citation

Angoulvant, Denis, et al. "NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View." American Journal of Cardiovascular Drugs, vol. 21, no. 5, 2021, p. 483, https://doi.org/10.1007/s40256-021-00471-z.